Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Solid Tumor Malignancy
×
Irinotecan
×
Clear all
Filters
3
NCT05177276
2022-01-04
Selinexor Combination Ph 1 Study
Hackensack Meridian Health
Phase 1/2
Withdrawn